跳至主要内容
临床试验/JPRN-UMIN000037483
JPRN-UMIN000037483已完成未知

Randomized controlled trial to evaluate the prediction of the immunotherapy response based on HLA-type. - Randomized controlled trial of HLA type-oriented therapy (JSCT trial).

The Japanese Society of Strategies for Cancer Research and Therapy0 个研究点目标入组 542 人开始时间: 2019年7月29日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
542

研究概览

简要总结

Our results showed that it is beneficial to examine HLA antigens preoperatively. We observed long term survivors who were given effective therapy, whereas those who died shortly after gastrectomy were given ineffective therapy. We, however, failed to find a specific HLA profile to treatment response.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 81years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Double cancer. 2. Mucosal and no lymph node metastasis. 3. Prior cytotoxic or radiation therapy. 4. Abnormal bone marrow, hepatic and renal function 5. Severe cardiac, hepatic and lung failure, and an attending doctor was considered unsuitable.

研究者

发起方
The Japanese Society of Strategies for Cancer Research and Therapy

相似试验